Ruijie Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ruijie Xiao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Peiyuan Tang
Department of Orthopedics, Xiangya Hospital, Central South University
2 shared publicationsTing Wen
Department of Orthopedics, Xiangya Hospital, Central South University
2 shared publicationsWenfeng Xiao
Department of Orthopedics, Xiangya Hospital, Central South University
2 shared publicationsAhmed Abdirahman
Department of Orthopedics, Xiangya Hospital, Central South University, Hunan, China
1 shared publication- Bangbao Lu
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China
1 shared publication Han Tan
Xiangya School of Medicine, Central South University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 22 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2604391
The impact of the COVID-19 pandemic on osteoporotic fractures: a systematic review and meta-analysis
Recent reports suggest that the COVID-19 pandemic and associated lockdowns may have influenced the epidemiology of osteoporotic fractures, but results vary across regions and fracture types. The aim of this study was to provide evidence-based insights into the impact of the pandemic on osteoporotic fracture incidence. We searched four databases (PubMed, Embase, Cochrane Library, and Web of Science) up to August 2025 for observational or retrospective studies comparing osteoporotic fracture incidence during the COVID-19 pandemic (2020) with the pre-pandemic period (2019). The primary outcome of interest was the change in fracture incidence, analysed using risk ratios (RR) with 95% confidence intervals (CI) in Review Manager 5.4. Subgroup analyses were performed by sex, geographic region, and fracture type. Nine studies meeting the inclusion criteria were analysed. Overall, "all types" of osteoporotic fractures showed a significant decrease during the pandemic (RR = 0.85, 95% CI 0.80-0.91, p < 0.0001). Specifically, forearm fractures decreased significantly (RR = 0.87, 95% CI 0.79-0.96, p = 0.002). However, for the most clinically significant fractures, no statistically significant global change was found for hip fractures (RR = 0.93, 95% CI 0.76-1.15, p = 0.14) or vertebral fractures (RR = 1.35, 95% CI 0.85-2.15, p = 0.20). In regional subgroup analysis, hip fracture incidence decreased significantly in South America (RR = 0.79, p = 0.0004) and in both males and females, but no significant change was observed in Europe (RR = 0.92, 95% CI 0.81-1.04, p = 0.17). During the COVID-19 pandemic, there was a decrease in the incidence of minor fractures, such as those of the forearm, likely due to reduced outdoor activity. However, the incidence of major osteoporotic fractures (hip and vertebral) remained stable globally, with significant reductions observed only in specific regions like South America.
- 22 December 2025
- Published by Taylor & Francis in Annals of Medicine
- Vol. 58 (1) , 2604391
Open AccessThe impact of the COVID-19 pandemic on osteoporotic fractures: a systematic review and meta-analysis
Recent reports suggest that the COVID-19 pandemic and associated lockdowns may have influenced the epidemiology of osteoporotic fractures, but results vary across regions and fracture types. The aim of this study was to provide evidence-based insights into the impact of the pandemic on osteoporotic fracture incidence. We searched four databases (PubMed, Embase, Cochrane Library, and Web of Science) up to August 2025 for observational or retrospective studies comparing osteoporotic fracture incidence during the COVID-19 pandemic (2020) with the pre-pandemic period (2019). The primary outcome of interest was the change in fracture incidence, analysed using risk ratios (RR) with 95% confidence intervals (CI) in Review Manager 5.4. Subgroup analyses were performed by sex, geographic region, and fracture type. Nine studies meeting the inclusion criteria were analysed. Overall, "all types" of osteoporotic fractures showed a significant decrease during the pandemic (RR = 0.85, 95% CI 0.80-0.91, p < 0.0001). Specifically, forearm fractures decreased significantly (RR = 0.87, 95% CI 0.79-0.96, p = 0.002). However, for the most clinically significant fractures, no statistically significant global change was found for hip fractures (RR = 0.93, 95% CI 0.76-1.15, p = 0.14) or vertebral fractures (RR = 1.35, 95% CI 0.85-2.15, p = 0.20). In regional subgroup analysis, hip fracture incidence decreased significantly in South America (RR = 0.79, p = 0.0004) and in both males and females, but no significant change was observed in Europe (RR = 0.92, 95% CI 0.81-1.04, p = 0.17). During the COVID-19 pandemic, there was a decrease in the incidence of minor fractures, such as those of the forearm, likely due to reduced outdoor activity. However, the incidence of major osteoporotic fractures (hip and vertebral) remained stable globally, with significant reductions observed only in specific regions like South America.
- Open Access
- 11 September 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 88, 103488
Safety of TNF-α inhibitors therapy in patients with rheumatoid arthritis: an umbrella review
- 11 September 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 88, 103488
Open AccessSafety of TNF-α inhibitors therapy in patients with rheumatoid arthritis: an umbrella review